Dual inhibition of braf-mapk and stat3 signaling pathways in resveratrol-suppressed anaplastic thyroid cancer cells with braf mutations

HIGHLIGHTS

• who: Meng-Di Lu et al. from the School of Medicine, South China University of Technology, Guangzhou, China have published the research work: Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations, in the Journal: (JOURNAL) of 17/Nov/2022
• what: This study aims to address the above issues using the Nthyori 3-1 human thyroid epithelial_cell line and THJ-11T, THJ-16T, and THJ-21T ATC cell lines. Because of the active roles of BRAF-mediated signaling in thyroid carcinogenesis, the status of the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.